Endovascular or surgical popliteal aneurysms exclusion – both with good results but for different patients.

Original title: A Multicentric Experience with Open Surgical Repair and Endovascular Exclusion of Popliteal Artery Aneurysms. Reference: R. Pulli et al. European Journal of Vascular and Endovascular Surgery, Volume 45, Issue 4, Pages 357-363.

 

Complications of a popliteal aneurysm may cause rupture, distal embolization or thrombosis with a risk of any of them affecting the lower limb. That’s why elective treatment of asymptomatic aneurysms larger than 20 mm is recommended. The surgery has good results although recently the possibility of endovascular stent graft exclusion has also emerged.

This retrospective multicenter registry analyzed the results of 312 popliteal aneurysms (178 treated with surgery and 134 endovascular) over a period of ten years. 

The choice of strategy was at the discretion of the treating physicians, although there were clear differences especially in the clinical presentation. The 71% treated as endovascular were asymptomatic. The opposite was true for those who received surgical treatment where 64.5% were symptomatic of claudication or acute ischemia. In the endovascular group stent grafts were used, (Hemobahn or Viabahn, WL Gore & Associates Inc, Flagstaff, AZ, USA), implanted most frequently by ipsilateral access. In the surgical group thrombosis was observed in six patients (3.3%), three of which could be resolved but the other three required major amputation. After follow-up at 12, 24 and 48-months, primary patency of this group was 78.8%, 77.1% and 63.4% respectively.  In the endovascular group seven patients developed thrombosis,  (9.7%), all could be resolved except for one patient who required major amputation. Primary patency of endovascular treatment at 12, 24 and 48 months was 79.1%, 76.9% and 73.4% respectively.

Conclusion:

In this study, which has the highest record of popliteal aneurysms, surgical or endovascular treatment was used in different patients, preferring the surgical strategy for acute presentation and endovascular for asymptomatic. Both strategies showed good results in the short and long term. 

Editorial comment:

You cannot directly compare the results of both strategies and the clinical presentation was often opposite. For the surgical group the results were better if used instead of autogenous vein graft. No randomized studies are currently available on this topic.

SOLACI.ORG

More articles by this author

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...